Department of Pharmacology, T. John College of Pharmacy.
World Journal of Biology Pharmacy and Health Sciences, 2025, 24(01), 106-113
Article DOI: 10.30574/wjbphs.2025.24.1.0851
Received on 12 August 2025; revised on 26 September 2025; accepted on 29 September 2025
Bipolar disorder is a complex psychiatric illness that is characterized by alternating episodes of mania and depression that significantly affect the quality of life. It is a chronic condition that has multifactorial pathophysiological mechanisms that remain incompletely understood, and therapeutic outcomes often fail to achieve long-term remission. This review visits the changing landscape of the development of bipolar disorder, in particular, the contributions of metabolic dysfunction and diabetes, which are increasingly acknowledged as important contributors to disease onset, progression, and treatment resistance. The review also explores current advancements, both pharmacological and non-pharmacological advancements for the management of the disease. By integrating the insights from several biological domains, the need for a broader and personalized treatment paradigm that goes beyond neurotransmitter theories is highlighted for improving patient outcomes.
Bipolar disorder; Diabetes Mellitus; Oxidative stress; Neuroinflamation; Treatment
Preview Article PDF
Varsha Velmurugan, Deborshi Nath, Vineeth Chandy and Visaga Perumal. Bridging Biology and Therapy: Advances in Management of Bipolar Disorder. World Journal of Biology Pharmacy and Health Sciences, 2025, 24(01), 106-113. Article DOI: https://doi.org/10.30574/wjbphs.2025.24.1.0851.